Bloomberg News

Generic Lipitor Supply Adequate as Ranbaxy Recalls Pills

November 29, 2012

Ranbaxy Laboratories Ltd. (RBXY)’s recall and production halt of its version of the cholesterol pill Lipitor won’t create a supply shortage, U.S. regulators said.

Ranbaxy has stopped making the generic pills while it investigates how glass particles got into the product, the Food and Drug Administration said today in a statement. The company, based near New Delhi, announced Nov. 23 it had recalled the medicine. The FDA said it hasn’t received any reports of patients being harmed.

To contact the reporter on this story: Drew Armstrong in New York at darmstrong17@bloomberg.net;

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net


Hollywood Goes YouTube
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus